Library / Repair / BPC-157

Body Protection Compound-157

BPC-157

Cited range Mostly preclinical

ClassGastric pentadecapeptide
Typical routes in papersSC, oral, local
Half-life contextShort plasma time in animals
EvidenceLarge animal literature; scarce controlled human trials

What it is

BPC-157 is a synthetic 15-amino-acid fragment derived from a protective protein found in gastric juice. It has been studied for decades, mainly by one research group, in models of gut injury, tendon/ligament damage, and vascular integrity.

Benefits in plain language

What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.

If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.

Mechanism of action

Proposed actions include interaction with the nitric-oxide system, stabilization of endothelium, and modulation of growth-factor signaling (including VEGF-related angiogenesis and FAK-paxillin pathways in fibroblasts). It is often described as cytoprotective rather than a classical receptor “drug.” Exact human receptor pharmacology is incomplete.

Possible side effects / caveats

Human safety data are thin. Theoretical concerns raised in reviews include unknown long-term angiogenic effects and the usual peptide risks (local irritation, contamination if a research vial is misused). Animal papers generally report a wide apparent safety margin; that is not a substitute for human toxicology.

Protocol ranges

Source tierAmountFrequency / durationNotes
Cited range200–500 mcg/dayOnce daily or split 1–2×; 4–8+ weeks common in community referencesMost repeated research-community figure
Cited rangeUp to ~600 mcg/dayDailyUpper end of many secondary summaries
Preclinical papersmcg/kg scalesModel-dependentDo not naively convert rodent mcg/kg to a human vial dose
No FDA-approved human dose. Treat every number as a literature pointer, not a treatment plan.